Adverse drug events in the prevention and treatment of COVID-19: A data mining study on the FDA adverse event reporting system

Background: In the emergent situation of COVID-19, off-label therapies and newly developed vaccines may bring the patients more adverse drug event (ADE) risks. Data mining based on spontaneous reporting systems (SRSs) is a promising and efficient way to detect potential ADEs to help health professio...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qiang, Duan, Shaojun, Liu, Yaxi, Yuan, Yinxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730807/
https://www.ncbi.nlm.nih.gov/pubmed/36506542
http://dx.doi.org/10.3389/fphar.2022.954359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730807/
https://www.ncbi.nlm.nih.gov/pubmed/36506542
http://dx.doi.org/10.3389/fphar.2022.954359

Ejemplares similares